SAN DIEGO, Oct. 4, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN - News) announced today the company has entered into discussions with several organizations regarding the establishment of adult stem cell repositories at the company's 15,000 sq. ft. facility. Chairman & CEO David Koos commented about these recent developments, stating, "The company has recently been approached by several entities seeking to develop adult stem cell repositories that dovetail into their overall business models. We see opportunities in working with organizations in areas including cancer stem cells, adult stem cell storage for future therapeutic usage and tumor banking for establishing cell lines for cancer research. I do see potential for initiation of these repositories in the near term."
Ceelox Update: Company Continues to Evolve Growth Strategy
TAMPA, FL--(Marketwire - 10/04/10) - Ceelox, Inc., (OTC.BB:CELO - News), (the "Company"), continues to focus on evolving their product line and company strategy to meet changes in the competitive landscape. With the recent announcements regarding industry consolidation, Ceelox has been aggressive in their product evolution and pursuit of a strategic partner....
JERUSALEM, October 4, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB:MFTH.ob - News), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, today announced positive developments relating to the production of a prototype of its patented medicinal locking device technology. The prototype has successfully passed the company's preliminary testing phase. The tests confirm the potential of the prototype to significantly reduce preventable drug-related injuries in hospitals. The purpose of the patented device is to physically prevent medication administration errors in hospitals. The device includes a syringe locking mechanism that works in concert with a bar-code reader and database system.